Synapse.patsnap.com

CoV2-OGEN1(Syneos Health)

WebCoV2-OGEN1 (Syneos Health): a SARS-CoV-2 S protein inhibitors Drug, Initially developed by Syneos Health, Inc., Now, its global highest R&D status is Phase …

Actived: 5 days ago

URL: https://synapse.patsnap.com/drug/059ae1cf793b4f0b9fe8b56f16a02a8e

What is Age-standardized Rate？

Web10 May 2024. 2 min read. Age-standardized rate refers to a statistical measure that allows for the comparison of health-related rates, such as disease incidence or …

Category: Health Go Health

MRT-8102 Preclinical Trials: Exploring Monte Rosa's Innovative …

WebMRT-8102 is anticipated to advance as a therapeutic option for managing inflammatory health conditions that result from the activity of the interleukin-1β and the NLRP3 …

Category: Health Go Health

Remix Therapeutics Initiates Phase 1 Trials of REM-422 for ACC …

WebThe U.S. FDA grants an Orphan Drug Designation to experimental treatments developed for rare health disorders affecting fewer than 200,000 U.S. residents. REM …

Category: Health Go Health

KH-001(Kanna Health)

WebKanna Health announces FDA and MHRA approvals to begin its Phase 1 clinical trial for the development of KH-001 as first FDA-approved treatment for …

Category: Health Go Health

EicOsis Begins Phase 1b Study for EC5026 in Clinical Settings

WebEicOsis Human Health, a biopharmaceutical enterprise focused on pioneering a unique class of pain relievers that are non-addictive and taken orally, targeting the …

Category: Health Go Health

Umbilical cord MSCs(Maternal and Child Health Hospital of Foshan

WebUmbilical cord MSCs(Maternal and Child Health Hospital of Foshan): a Stem cell replacements Drug, Initially developed by Foshan Maternal and Child Health …

Category: Health Go Health

Keratinocyte growth factor(The University of Arizona Health …

WebThe addition of palifermin limits severe regimen-related toxicities and decreases readmissions and duration of hospital stay. This and other measures are …

Category: Health Go Health

NCI Healthcare LLC

WebTop investment priorities include cybersecurity (55%), electronic health record modernization (46%), digital care (32%) and advanced analytics, AI and machine …

Category: Health Go Health

Recombinant human anti-PD-1 monoclonal antibody(Shanghai …

WebTislelizumab (®;; Tileilizhu Dankang Zhusheye) is an anti-human programmed death receptor-1 (PD-1) monoclonal IgG4 antibody that is being developed by BeiGene …

Category: Health Go Health